Bold Themes

Viotika Life Sciences Inc. is a Canadian biotechnology company focused on research into antimicrobial resistance (AMR), a growing global health challenge that is making conventional antibiotics less effective against infections. The company describes its work as an effort to develop a new approach to addressing AMR, noting the long gap since a new class of antibiotics was introduced.

Viotika’s research platform is presented as a potential new class of treatment, but the available information does not identify specific medicines or indicate that products are currently available for sale. The company is working toward becoming the world’s first Indigenous-majority-owned biotechnology company dedicated to solving antimicrobial resistance. Its website provides information about the science behind its work, its team, company news, and opportunities to schedule a consultation.

Viotika lists locations in Winnipeg, Manitoba, Canada, and Littleton, Massachusetts, USA. Through its research, the company aims to contribute to efforts to address the serious threat posed by drug-resistant infections